Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
Metrics to compare | MBXBF | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMBXBFPeersSector | |
---|---|---|---|---|
P/E Ratio | −111.9x | −7.3x | −0.7x | |
PEG Ratio | 1.03 | −0.14 | 0.00 | |
Price/Book | 1.2x | 0.1x | 2.6x | |
Price / LTM Sales | 1.7x | 4.0x | 3.4x | |
Upside (Analyst Target) | - | 86.2% | 36.2% | |
Fair Value Upside | Unlock | 3.6% | 4.1% | Unlock |